Weston Blakeslee, Ph.D.
Chief Clinical Officer
Wes provides strategic leadership for RxRevu’s clinical team. He is responsible for developing the clinical strategy for the SwiftRx® product suite and co-leading the innovation arm of the company. Wes also is the co-lead for the ONC’s FHIR At Scale Task Force (FAST) Pilots Tiger Team, focused on improving national interoperability.
Wes brings seven years of research experience in a wide array of topics, including salmonella pathogenesis, human arterial aging, protein biochemistry, cancer stem cells, clinical trial design and cardiovascular pharmacology. He has secured approximately $1 million in non-dilutive funding to pursue innovative clinical decision support projects focused on antimicrobial stewardship, heart failure, behavioral health/PGx and general pediatrics.
Wes earned his Ph.D. in pharmacology from the University of Colorado-Anschutz Medical Campus. In his spare time, he enjoys playing tennis, snowboarding and spending quality time with his family and friends.
Contact us today to learn how your organization can benefit from a partnership with RxRevu.